Biomind Labs — Regulatory Filings 2021

Apr 15, 2021

FORM 13-501F2 CLASS 2 REPORTING ISSUERS – PARTICIPATION FEE

MANAGEMENT CERTIFICATION

I, ARVIN RAMOS ____________________ , an officer of the reporting issuer noted below have examined this Form 13-501F2 (the Form ) being submitted hereunder to the Alberta Securities Commission and certify that to my knowledge, having exercised reasonable diligence, the information provided in the Form is complete and accurate. _________________________________ _________________________________ (s) ARVIN RAMOS April 15, 2021 Name: Date: ARVIN RAMOS Title: CFO Reporting Issuer Name: CROSSWINDS HOLDINGS INC. End date of previous financial year: December 31, 2020

Financial Statement Values:

(Use stated values from the audited financial statements of the reporting issuer as of the end of its previous financial year)

Retained earnings or deficit	$	-14,979,160	(A)
Contributed surplus	$	13,656,502	(B)
Share capital or owners’ equity, options, warrants and preferred
shares (whether such shares are classified as debt or equity for
financial reporting purposes)	$	1,447,473.00	(C)
Non-current borrowings (including the current portion)	$		(D)
Financeleases (including the current portion)	$		(E)
Non-controllinginterest	$		(F)
Items classified on the statement of financial position as non-
current liabilities(and not otherwise listed above)	$		(G)
Any other item forming part of equity and not set out specifically
above	$	-91,869.00	(H)

Capitalization for the previous financial year
(Add items(A)through(H))$32,946.00
Participation Fee$400.00
Late Fee,if applicable$
Total Fee Payable$400.00
(Participation Fee plus Late Fee)